SonoClear AS Receives FDA Breakthrough Designation for SonoClear® System
Innovative Fluid Designed to Assist in Ultrasound-Guided Surgical Resection of Brain Tumors – First Fully Norwegian Owned Company to be Granted Breakthrough Device Designation – SonoClear AS today announced that the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) has designated the SonoClear® System as a Breakthrough Device […]